ATE549638T1 - 13c-mr-bildgebung oder spektroskopie von zelltod - Google Patents

13c-mr-bildgebung oder spektroskopie von zelltod

Info

Publication number
ATE549638T1
ATE549638T1 AT07808605T AT07808605T ATE549638T1 AT E549638 T1 ATE549638 T1 AT E549638T1 AT 07808605 T AT07808605 T AT 07808605T AT 07808605 T AT07808605 T AT 07808605T AT E549638 T1 ATE549638 T1 AT E549638T1
Authority
AT
Austria
Prior art keywords
imaging
spectroscopy
cell death
pyruvate
relates
Prior art date
Application number
AT07808605T
Other languages
English (en)
Inventor
Kevin Brindle
Samuel Day
Mikko Kettunen
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Application granted granted Critical
Publication of ATE549638T1 publication Critical patent/ATE549638T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy
    • G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/483—NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/4828—Resolving the MR signals of different chemical species, e.g. water-fat imaging

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • High Energy & Nuclear Physics (AREA)
  • General Health & Medical Sciences (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Signal Processing (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
AT07808605T 2006-08-18 2007-08-17 13c-mr-bildgebung oder spektroskopie von zelltod ATE549638T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20063702 2006-08-18
PCT/NO2007/000286 WO2008020764A1 (en) 2006-08-18 2007-08-17 13c-mr imaging or spectroscopy of cell death

Publications (1)

Publication Number Publication Date
ATE549638T1 true ATE549638T1 (de) 2012-03-15

Family

ID=38690525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07808605T ATE549638T1 (de) 2006-08-18 2007-08-17 13c-mr-bildgebung oder spektroskopie von zelltod

Country Status (8)

Country Link
US (1) US8951500B2 (de)
EP (1) EP2052273B1 (de)
JP (1) JP5363320B2 (de)
CN (1) CN101506679B (de)
AT (1) ATE549638T1 (de)
ES (1) ES2381380T3 (de)
PL (1) PL2052273T3 (de)
WO (1) WO2008020764A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008020765A2 (en) * 2006-08-18 2008-02-21 Ge Healthcare As Imaging medium comprising lactate and hyperpolarised 13c-pyruvate
US20100016706A1 (en) * 2006-12-08 2010-01-21 Molecular Image, Inc. Methods for diagnosis and monitoring of neurologic diseases using magnetic resonance methods
GB0713074D0 (en) * 2007-07-05 2007-08-15 Univ London A method of hyperpolarising a magnetic resonance agent
JP5868311B2 (ja) * 2009-04-02 2016-02-24 ジーイー・ヘルスケア・リミテッド 炎症又は感染の検出のための過分極１３ｃピルビン酸塩を含む磁気共鳴造影媒体の使用
WO2012027274A2 (en) * 2010-08-23 2012-03-01 The Regents Of The University Of California Compositions and methods for imaging
US9452409B2 (en) 2011-04-22 2016-09-27 Vanderbilt University Para-hydrogen polarizer
KR20150111353A (ko) 2013-01-31 2015-10-05 브라코 이미징 에스.피.에이. Mr에서 대사 마커로서 사용되는 과분극화된 에스테르
WO2015000838A1 (en) * 2013-07-01 2015-01-08 Bracco Imaging Spa Hyperpolarized 1-13c-1,1-bis(acetoxy(methyl))-2,2'-cyclopropane as metabolic marker for mr
EP2863229A1 (de) 2013-10-15 2015-04-22 Technische Universität München pH-Biosensoren auf Basis von Verbindungen mit pH-sensiblen Enolgruppen zur Magnetresonanzbildgebung und Spektroskopie und deren Verwendungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822816A (en) * 1987-04-10 1989-04-18 Oxycal Laboratories, Inc. Compositions and methods for administering vitamin C
US6278893B1 (en) * 1998-01-05 2001-08-21 Nycomed Imaging As Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent
DE69939123D1 (de) * 1999-08-30 2008-08-28 Ester C Company Verwendungen und zusammensetzungen für selektive krebs-chemotherapie
WO2006011810A2 (en) * 2004-07-30 2006-02-02 Ge Healthcare As Mr imaging method for the discrimination between healthy and tumour tissue
US8980224B2 (en) * 2004-11-19 2015-03-17 Ge Healthcare As Method of cardiac imaging

Also Published As

Publication number Publication date
CN101506679B (zh) 2013-03-06
US20100226859A1 (en) 2010-09-09
WO2008020764A1 (en) 2008-02-21
CN101506679A (zh) 2009-08-12
EP2052273B1 (de) 2012-03-14
JP5363320B2 (ja) 2013-12-11
EP2052273A1 (de) 2009-04-29
JP2010501482A (ja) 2010-01-21
ES2381380T3 (es) 2012-05-25
PL2052273T3 (pl) 2012-08-31
US8951500B2 (en) 2015-02-10

Similar Documents

Publication Publication Date Title
ATE549638T1 (de) 13c-mr-bildgebung oder spektroskopie von zelltod
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
CY1118187T1 (el) Χημικες ενωσεις
CY1117721T1 (el) Κυτταρα προελευσης αμνιακου υγρου
GT201200189A (es) Antagonistas de pcsk9
ATE471324T1 (de) Triazolophthalazine
EA201270553A1 (ru) Ингибиторы тирозинкиназы брутона
EA200901313A1 (ru) Ингибиторы тирозинкиназы брутона
ECSP078013A (es) Inhibidores heterocíclicos de mek y métodos de uso de ellos
DE602006015793D1 (de) Proteolipidmembran und lipidmembranen-biosensor
CR20110066A (es) Anticuerpos monoclonales contra el factor tisular inhibidor de la via
GT200600112A (es) Composiciiones de tigeciclina y metodos de preparacion
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
ECSP10010344A (es) Azolilmetiloxiranos, su uso y agentes que los contienen
EA201200323A1 (ru) Соединения и композиции, как ингибиторы протеинкиназы
EA201170288A1 (ru) Оксабициклогептаны и оксабициклогептены, их получение и применение
EA201101520A1 (ru) Способы диагностики онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
CY1109985T1 (el) Αναστολεις πρωτεασωματος και μεθοδοι χρησης αυτων
ITMO20050067A1 (it) Mezzi di illuminazione e metodo per ottenere mezzi di illuminazione.
CL2007003622A1 (es) Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales.
BR112012000934A2 (pt) cassetes e métodos de utilizacao destes
EA201270325A1 (ru) Способы лечения саркомы с использованием эпиметаболической сдвигающей добавки (кофермента q10)
ATE548050T1 (de) Diagnoseverfahren
BRPI1006379A2 (pt) método e analisador de dados
EA200801676A1 (ru) Комбинация производных триазина и сенсибилизаторов инсулина